Marc Oczachowski, EDAP’s chief executive officer, stated that the company strongly believes Jorge Litter in Argentina, H. Strattner in Brazil and UMS in Chile are the right partners to develop and build our presence in these countries as part of an ongoing effort to drive geographic expansion of our minimally-invasive HIFU option to patients with localized prostate cancer. Several clinical institutions have been showing strong interest in offering Ablatherm-HIFU to their patients and we are very enthusiastic to now provide them with a solution.
